华北制药 (600812)
North China Pharmaceutical Co., Ltd.
K-Line Chart
No K-line data
Stock Details
1. Key Indicators
- Total Shares(W): 171573.04
- Circulating A-Shares(W): 171573.04
- Earnings Per Share(RMB): 0.0920
- Net Assets Per Share(RMB): 3.2087
- Operating Revenue(W RMB): 748482.86
- Total Profit(W RMB): 28721.56
- **Net Profit Attributable to Parent(W RMB) **: 15850.40
- Net Profit Growth Rate(%): 54.69
- Weighted Return on Equity(%): 2.8980
- Operating Cash Flow Per Share(RMB): 0.3860
- Undistributed Profit Per Share(RMB): -0.2466
- Capital Reserve Per Share(RMB): 2.2555
2. Main Business
The main business covers:
- Research, development, production and sales of pharmaceutical products
3. Company Basic Information
- Company Name: North China Pharmaceutical Co., Ltd.
- Listing Date: 1994-01-14
- Industry: Pharmaceutical Manufacturing
- Address: No. 388 Heping East Road, Shijiazhuang City, Hebei Province
- Website: https://www.ncpc.com/
- Company Profile: The company's predecessor was North China Pharmaceutical Factory. In August 1992, it began restructuring into a joint-stock company, converting the original company's net assets into 491.7791 million state-owned shares. After the initial public offering from August 1992 to October 1993, the total number of shares at the time of listing was 660 million shares; 21.608598 million internal employee shares were listed for trading on September 22, 1994.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Jizhong Energy Co., Ltd. | General Legal Person | 41308.05 | 24.08 |
| 2 | North China Pharmaceutical Group Co., Ltd. | General Legal Person | 34147.16 | 19.90 |
| 3 | Jizhong Energy Group Co., Ltd. | General Legal Person | 18914.67 | 11.02 |
| 4 | Central Huijin Asset Management Co., Ltd. | Special Legal Person | 5491.66 | 3.20 |
| 5 | Hong Kong Securities Clearing Company Ltd. | Northbound Funds | 2005.31 | 1.17 |
| 6 | Caida Securities Co., Ltd. | Securities Company | 1320.00 | 0.77 |
| 7 | Southern China Securities 1000 ETF | Fund | 784.47 | 0.46 |
| 8 | ChinaAMC China Securities 1000 ETF | Fund | 466.25 | 0.27 |
5. Concept Sectors
- Biological Vaccines
- Xiongan New Area
- Gene Concept
- Vitamins
- Generic Drugs
- Fertilizer Concept
- Hepatitis Concept
- Innovative Drugs
- Synthetic Biology
- DeepSeek
Remarks
- Data update date: 2025-10-24
- Data source: Public market information
